Oleic Acid Enhances All-Trans Retinoic Acid Loading in Nano-Lipid Emulsions

References

1. 1.↵
   1. Otsuki T.,
   2. Sakaguchi H.,
   3. Hatayama T.,
   4. Wu P.,
   5. Takata A.,
   6. Hyodoh F.

   Effects of all-trans retinoic acid (ATRA) on human myeloma cells. Leuk. Lymphoma 2003, 44 (10), 1651–1656.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Lengfelder E.,
   2. Saussele S.,
   3. Weisser A.,
   4. Buchner T.,
   5. Hehlmann R.

   Treatment concepts of acute promyelocytic leukemia. Crit. Rev. Oncol. Hematol. 2005, 56 (2), 261–274.

   OpenUrlPubMedWeb of Science
3. 3.↵
   1. Muindi J.,
   2. Frankel S. R.,
   3. Miller W. H.,
   4. Jakubowski A. Jr.,
   5. Scheinberg D. A.,
   6. Young C. W.,
   7. Dmitrovsky E.,
   8. Warrell R. P. Jr.

   Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid “resistance” in patients with acute promyelocytic leukemia. Blood 1992, 79 (2), 299–303.

   OpenUrlAbstract/FREE Full Text
4. 4.↵
   1. Ozpolat B.,
   2. Lopez-Berestein G.

   Liposomal-all-trans-retinoic acid in treatment of acute promyelocytic leukemia. Leuk. Lymphoma 2002, 43 (5), 933–941.

   OpenUrlPubMed
5. 5.↵
   1. Estey E.,
   2. Koller C.,
   3. Tsimberidou A. M.,
   4. O'Brien S.,
   5. Beran M.,
   6. Cortes J.,
   7. Tirado-Gomez M.,
   8. Lopez-Berestein G.,
   9. Kantarjian H.

   Potential curability of newly diagnosed acute promyelocytic leukemia without use of chemotherapy: the example of liposomal all-trans retinoic acid. Blood 2005, 105 (3), 1366–1367.

   OpenUrlFREE Full Text
6. 6.↵
   1. Lim S. J.,
   2. Lee M. K.,
   3. Kim C. K.

   Altered chemical and biological activities of all-trans retinoic acid incorporated in solid lipid nanoparticle powders. J. Controlled. Release 2004, 100 (1), 53–61.

   OpenUrlPubMed
7. 7.↵
   1. Kawakami S.,
   2. Opanasopit P.,
   3. Yokoyama M.,
   4. Chansri N.,
   5. Yamamoto T.,
   6. Okano T.,
   7. Yamashita F.,
   8. Hashida M.

   Biodistribution characteristics of all-trans retinoic acid incorporated in liposomes and polymeric micelles following intravenous administration. J. Pharm. Sci. 2005, 94 (12), 2606–2615.

   OpenUrlPubMed
8. 8.↵
   1. Opanasopit P.,
   2. Ngawhirunpat T.,
   3. Rojanarata T.,
   4. Choochottiros C.,
   5. Chirachanchai S.

   N-phthaloylchitosan-g-mPEG design for all-trans retinoic acid-loaded polymeric micelles. Eur J Pharm Sci. 2007, 30 (5), 424–431.

   OpenUrlPubMed
9. 9.↵
   1. Hwang S. R.,
   2. Lim S. J.,
   3. Park J. S.,
   4. Kim C. K.

   Phospholipid-based microemulsion formulation of all-trans-retinoic acid for parenteral administration. Int. J. Pharm. 2004. 276 (1–2), 175–183.

   OpenUrlPubMed
10. 10.↵
    1. Chinsriwongkul A.,
    2. Opanasopit P.,
    3. Ngawhirunpat T.,
    4. Chareansriwilaiwat N.,
    5. Sila-On W.,
    6. Ruktanonchai U.

    Physicochemical properties of lipid emulsions formulated with high-load all-trans-retinoic acid. PDA J. Pharm. Sci. Technol. 2007, 61 (6), 461–471.

    OpenUrlAbstract/FREE Full Text
11. 11.↵
    1. Prankerd R. J.,
    2. Stella V. J.

    The use of oil-in-water emulsion as a vehicle for parenteral drug administration. J. Parent. Sci. Technol. 1990, 44 (3), 139–149.

    OpenUrl
12. 12.↵
    1. Sznitowka M.,
    2. Janicki S.,
    3. Dabrowska E.,
    4. Zurowska-Pryczkowska K.

    Submicron emulsions as drug carriers. Studies on destabilization potential of various drugs. Eur. J. Pharm. Sci. 2001, 12 (3), 175–179.

    OpenUrlPubMed
13. 13.↵
    1. Benita S.,
    2. Friedman D.,
    3. Weinstock M.

    Physostigmine emulsion: a new injectable controlled release delivery system. Int. J. Pharm. 1986, 30 (1), 47–55.

    OpenUrl
14. 14.↵
    1. Myers R. A.,
    2. Stella V. J.

    Systemic bioavailability of penclomedine (NSC-338720) from oil-in-water emulsions administered intraduodenally to rats. Int. J. Pharm. 1992, 78 (2–3), 217–220.

    OpenUrl
15. 15.↵
    1. Kaur I. P.,
    2. Rana C.,
    3. Singh H.

    Development of effective ocular preparations of antifungal agents. J. Ocul. Pharmacol. Ther. 2008, 24 (5), 481–493

    OpenUrlCrossRefPubMed
16. 16.↵
    1. Tamilvanan S.,
    2. Benita S.

    The potential of lipid emulsion for ocular delivery of lipophilic drugs. Eur. J. Pharm. Biopharm. 2004, 58 (2), 357–368.

    OpenUrlCrossRefPubMed
17. 17.↵
    1. Gershkovich P.,
    2. Wasan K. M.,
    3. Barta C. A.

    A review of the application of lipid-based systems in systemic, dermal/transdermal, and ocular drug delivery. Crit Rev. Ther. Drug Carrier Syst. 2008, 25 (6), 545–84.

    OpenUrlPubMed
18. 18.↵
    1. Levy M. Y.,
    2. Schutze W.,
    3. Fuhrer C.,
    4. Benita S.

    Characterization of diazepam submicron emulsion interface: role of oleic acid. J. Microencapsul. 1994, 11 (1), 79–92.

    OpenUrlPubMed
19. 19.↵
    1. Tamilvanan S.,
    2. Schmidt S.,
    3. Müller R. H.,
    4. Benita S.

    In vitro adsorption of plasma proteins onto the surface (charges) modified-submicron emulsions for intravenous administration. Eur. J. Pharm Biopharm. 2005, 59 (1), 1–7.

    OpenUrlCrossRefPubMed
20. 20.↵
    1. Caddeo C.,
    2. Manconi M.,
    3. Valenti D.,
    4. Pini E.,
    5. Sinico C.

    Photostability and solubility improvement of β-cyclodextrin-included tretinoin. J. Incl. Phenom. Macrocycl. Chem. 2007, 59 (3–4), 293–300.

    OpenUrl
21. 21.↵
    1. Klang S.,
    2. Benita S.

    Design and evaluation of submicron emulsions as colloidal drug carriers for intravenous administration. In Submicron Emulsions in Drug Targeting and Delivery; Harwood Academic Publishers: Singapore, 1998; pp 119–152.
22. 22.↵
    1. Driscoll D. F.,
    2. Giampietro K.,
    3. Wichelhaus D. P.,
    4. Peterss H.,
    5. Nehne J.,
    6. Niemann W.,
    7. Bistrian B. R.

    Physicochemical stability assessments of lipid emulsions of varying oil composition. Clin. Nutr. 2001, 20 (2), 151–7.

    OpenUrlCrossRefPubMedWeb of Science
23. 23.↵
    1. Brisaert M.,
    2. Plaizier-Vercammen J.

    Investigation on the Photostability of a tretinoin lotion and stabilization with additives. Int. J. Pharm. 2000, 199 (1), 49–57.

    OpenUrlPubMed
24. 24.↵
    1. Lin H. S.,
    2. Chean C. S.,
    3. Ng Y. Y.,
    4. Chan S. Y.,
    5. Ho P. C.

    2-hydroxypropyl-beta-cyclodextrin increases aqueous solubility and photostability of all-trans-retinoic acid. J. Clin. Pharm. Ther. 2000, 25 (4), 265–269.

    OpenUrlPubMed
25. 25.↵
    1. Washington C.,
    2. Davis S.

    Aging effects in parenteral fat emulsions: The role of fatty acids. Int. J. Pharm. 1987, 39 (1–2), 33–37.

    OpenUrl
26. 26.↵
    1. Brisaert M. G.,
    2. Everaerts I.,
    3. Plaizier-Vercammen J. A.

    Chemical stability of tretinoin in dermatological preparations. Pharm. Acta Helv. 1995, 70 (2), 161–166.

    OpenUrl
27. 27.↵
    1. Carlotti M. E.,
    2. Rossatto V.,
    3. Gallarate M.

    Vitamin A and vitamin A palmitate stability over time and under UVA and UVB radiation. Int. J. Pharm. 2002, 240 (1–2), 85–94.

    OpenUrlPubMed
28. 28.↵
    1. Ioele G.,
    2. Cione E.,
    3. Risoli A.,
    4. Genchi G.,
    5. Ragno G.

    Accelerated photostability study of tretinoin and isotretinoin in liposome formulations. Int. J. Pharm. 2005, 293 (1–2), 251–260.

    OpenUrlPubMed
29. 29.↵
    1. Manconi M.,
    2. Valenti D.,
    3. Sinico C.,
    4. Lai F.,
    5. Loy G.,
    6. Fadda A. M.

    Niosomes as carriers for tretinoin. II. Influence of vesicular incorporation on tretinoin photostability. Int. J. Pharm. 2003, 260 (2), 261–272.

    OpenUrlPubMed
30. 30.↵
    1. Shah K. A.,
    2. Date A. A.,
    3. Joshi M. D.,
    4. Patravale V. B.

    Solid lipid nanoparticles (SLN) of tretinoin: potential in topical delivery. Int. J. Pharm. 2007, 345 (1–2), 163–171.

    OpenUrlPubMed
31. 31.↵
    1. Tan X.,
    2. Meltzer N.,
    3. Lindenbaum S.

    Determination of the kinetics of degradation of 13-cis retinoic acid and all-trans retinoic acid in solution. J. Pharm. Biomed. Anal. 1993, 11 (9), 817–822.

    OpenUrlPubMed
32. 32.↵
    1. Ourique A. F.,
    2. Pohlmann A. R.,
    3. Guterres S. S.,
    4. Beck R. C.

    Tretinoin-loaded nanocapsules: Preparation, physicochemical characterization, and photostability study. Int. J. Pharm. 2008, 352 (1–2), 1–4.

    OpenUrlPubMed
33. 33.↵
    1. Yuan H.,
    2. Wang L. L.,
    3. Du Y. Z.,
    4. You J.,
    5. Hu F. Q.,
    6. Zeng S.

    Preparation and characteristics of nanostructured lipid carriers for control-releasing progesterone by melt-emulsification. Colloids Surf. B Biointerfaces 2007, 60 (2), 174–179.

    OpenUrlPubMed